Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - COST OF REVENUE
Cost of Revenue ANAB - AnaptysBio, Inc.
2.38 M
LAST VALUE
-84.47%
2 YEAR CAGR
-46.88%
5 YEAR CAGR
-12.29%
10 YEAR CAGR